Company Vineet Laboratories Limited

VINEETLAB

INE505Y01010

Pharmaceuticals

Market Closed - NSE India S.E. Other stock markets 04:35:10 03/07/2026 pm IST			5-day change	1st Jan Change
33.65 ^INR	+0.09%		-1.03%	-8.51%

29/05	Vineet Laboratories Limited Announces Resignation of Ramesh Kumar Bandari from Company Secretary and Compliance Officer and Ceases to Be Key Managerial Personnel, Effective May 29, 2026	CI
14/02	Vineet Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025	CI

Business description: Vineet Laboratories Limited

Vineet Laboratories Limited is an India-based company engaged in the business of drug intermediates and bulk drugs. The Company specializes in pharmaceutical intermediates and fine chemicals. Its active pharmaceutical ingredient (API) intermediates products include Lopinavir, Ritonavir, Efavirenz, Nadolol, Glimepiride, Celecoxib, and Piroctone Olanine. Its fine chemicals and reagents include Isopropyl-beta-D-thiogalactopyranoside, 4-Nitrophenyl phosphate disodium salt, 5-Bromo-4-chloro-3-indolyl-beta-D-galactopyranoside (X-Gal), 5-Acetyl thiophene-2-carboxilic acid, n-Butyl Lithium, n-Butyl magnesium chloride, 3-Furaldehyde, 3-bromofuran, 1-methyl-imidazole-2-carboxaldehyde, 6-Aminouracil, Ethyldiazo acetate, and Phenylboronic acid. The Company also exports API intermediates, fine chemicals, and custom synthesis molecules.

Number of employees: 57

Sales by Activity: Vineet Laboratories Limited

Fiscal Period: March	2021 (INR)	2022 (INR)	2023 (INR)	2024 (INR)	2025 (INR)
Active Pharmaceuticals Ingredient and Intermediates	243.48Cr	191.17Cr	212.29Cr	150.96Cr	77Cr

See all business segments

Geographical breakdown of sales: Vineet Laboratories Limited

Fiscal Period: March	2021 (INR)	2022 (INR)	2023 (INR)	2024 (INR)	2025 (INR)
India	242.4Cr	190.31Cr	203.31Cr	124.37Cr	75Cr
Unallocated	20.66L	85.28L	5.39Cr	3.4Cr	-
Export	87.3L	58T	3.59Cr	23Cr	-

See all geographic segments

Executive Committee: Vineet Laboratories Limited

Manager	Title	Age	Since
Venkata Ramana Gaddam CEO	Chief Executive Officer	56	10/11/2016
Satyanarayana Raju Bhupathiraju DFI	Director of Finance/CFO	76	01/01/2021
Pavani Srinivasa Rao HRO	Human Resources Officer	-	-
B V Ramakrishna AUD	Comptroller/Controller/Auditor	-	-

See VINEET LABORATORIES LIMITED governance

Composition of the Board of Directors: Vineet Laboratories Limited

Director	Title	Age	Since
Venkata Ramana Gaddam BRD	Director/Board Member	56	10/11/2016
Satyanarayana Raju Bhupathiraju BRD	Director/Board Member	76	10/11/2016
Dilip Vishnu Acharekar CHM	Chairman	73	16/11/2020
Alluri Ranga Raju BRD	Director/Board Member	52	-
Premananda Reddy Vennapusa BRD	Director/Board Member	-	15/09/2025
Jasmin Kunal Tailor BRD	Director/Board Member	-	09/11/2025

Composition of the Board of Directors

Company details: Vineet Laboratories Limited

Vineet Laboratories Ltd.

5-5-160, Malleswari Nilayam

500074, Hyderabad

+91 40 2412 8833

http://www.vineetlabs.co.in

address Vineet Laboratories Limited(VINEETLAB)

Other Pharmaceuticals

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
VINEET LABORATORIES LIMITED	+0.09%	-1.03%	+1.54%	-35.97%	67.88L
ELI LILLY AND COMPANY	+1.86%	+0.48%	+55.50%	+163.08%	1,08200Cr
JOHNSON & JOHNSON	+3.57%	+3.29%	+68.60%	+61.03%	63TCr
ABBVIE INC.	+3.99%	+3.05%	+37.93%	+93.37%	46TCr
ROCHE HOLDING AG	+3.86%	+1.64%	+32.57%	+24.89%	34TCr
ASTRAZENECA PLC	-0.56%	+0.96%	+41.67%	+39.35%	30TCr
NOVARTIS AG	-0.08%	+1.30%	+32.15%	+44.48%	29TCr
NOVO NORDISK A/S	-1.54%	+2.81%	-25.35%	-39.61%	22TCr
AMGEN INC.	+3.55%	+4.41%	+25.45%	+66.28%	20TCr
GILEAD SCIENCES, INC.	+4.21%	+2.65%	+17.47%	+71.11%	16TCr
Average	+1.90%	+4.02%	+28.75%	+48.80%	36.92TCr
Weighted average by Cap.	+2.25%	+5.53%	+42.31%	+83.31%